Bourne Lent Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.96M |
| 2 |
Idexx Laboratories
IDXX
|
+$2.27M |
| 3 |
Adobe
ADBE
|
+$1.82M |
| 4 |
United Parcel Service
UPS
|
+$1.5M |
| 5 |
SE
Spectra Energy Corp Wi
SE
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$71.4K |
| 2 |
ExxonMobil
XOM
|
+$43.7K |
| 3 |
Intel
INTC
|
+$21.5K |
| 4 |
Microchip Technology
MCHP
|
+$9.44K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.66% |
| 2 | Technology | 25.53% |
| 3 | Communication Services | 8.53% |
| 4 | Industrials | 4.25% |
| 5 | Financials | 3.17% |
Similar funds
Bourne Lent Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, Bourne Lent Asset Management held 59 positions worth $168M, up 23% from $136M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Bourne Lent Asset Management deployed $26.3M of net new capital in Q4 2016, opening 9 new positions and adding to 34 existing holdings. Its largest new stake was CenterPoint Energy: 22,300 shares worth $549K.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 51% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was St Jude Medical, an estimated $71.4K trimmed.
- Bourne Lent Asset Management's largest Q4 2016 buy was CenterPoint Energy: 22,300 shares worth $549K.
- Bourne Lent Asset Management added most to Celgene Corp in Q4 2016, an estimated $2.96M increase.
- Bourne Lent Asset Management's biggest Q4 2016 reduction was St Jude Medical, cutting an estimated $71.4K.
- Bourne Lent Asset Management's ten largest holdings make up 72% of its $168M portfolio in Q4 2016.
- Bourne Lent Asset Management opened 9 new positions and closed 0 in Q4 2016.
- Bourne Lent Asset Management's portfolio value rose 23% quarter-over-quarter to $168M.
Based on Bourne Lent Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.